Stephanie Reed, Ph.D., is the Director of Translational Product Development at Secant Group, a textiles and biomaterials company outside of Philadelphia. At Secant Group, Dr. Reed leads a team of scientists whose goal is to launch new biomaterial polymers for commercial use in controlled release drug products, biomedical devices, and tissue engineering applications. Dr. Reed garners 14-plus years of experience in drug delivery, biomaterials, 3D-printing technologies, regulatory submission, and product commercialization. Dr. Reed earned a BS in mechanical engineering at Massachusetts Institute of Technology, and an M.S. and Ph.D. in biomedical engineering at University of California Los Angeles.